spacer

AltSplice Human Release 1 (May 2004)

Introduction

The data in his release is generated for 'known genes' as annotated in Ensembl 19.34b2. The extracted nucleotide region includes the gene region as defined in EnsEMBL. Such a region is extended both at the 5' and 3' ends by 3000 bases. Human EST and mRNA (transcript) sequences are mapped to these extended gene regions. Transcript confirmed introns and exons are delineated from these alignments. The matching transcript sequences are further classified into groups in a manner that each of these groups represents an isoform splice pattern. Each group is represented by a transcript representative structure - called transcript class.

Such isoform transcript structures are compared with one another to delineate the alternative events. Thus the presented data lists all the alternative splice events as seen in the observed transcripts for a gene. The basic events that are identified in this work are: exon isoforms (extension/truncation of an exon), cassette exons (an exon is present in one transcript but absent in an isoform of the transcript), alternating exons (exons are used in alternative transcripts in a mutually exclusive manner), and intron retention (a nucleotide region is used as an exon in a transcript while it is an intron in an alternative transcript). The latter three events (namely cassette exon, alternating exon, intron retention) are further characterised as 'complex' or 'simple' depending on whether the 5' or/and 3' flanking exons also undergo modifications (e.g. the flanking exon may be extended or truncated or the exon that flanks a retained intron is cassetted or alternated).
SNPs have been mapped to our data and we display them for features as well as for individual events.

We have implemented, in this release, integration of AEdb with AltSplice (for both human and mouse entries). Entries that are common between AltSplice and AEdb are associated and are indicated so in the dispay pages that are resultant of queries to Altsplice and/or AEdb. Queries can be raised for common entries. AltSplice exons and splice events that have experimental evidence from AEdb are indicated so. In addition, we have built a wrapper that passes on queries to both the AEdb and AltSplice.

We have further implemented SplicePatternViewer to visualise the isoform splice patterns. Annotation pertaining the expression states of the isoforms is being added to the data.

We will carry out further work on this data towards annotating through various means and towards implementing an oracle version of the database along with query tools. As soon as these take place we will update this page to reflect the new data and/or tools.

Documentation

Concise documentation of the procedure followed to produce this data and the naming conventions used is available in PDF format. The document is a work in progress and will be updated now and then to reflect now developments.

Statistics

Gene set

Start-up gene set (Ensembl 19.34b2) 19599 human 'known' genes
After cleanup 19134 genes
No. of genes with one or more confirmed intron/exon features 14899

Grand totals of genes, transcript sequences, transcript classes, and events

Genes 14899

EST/mRNA sequences


568656

   
Confirmed introns 155949

Confirmed exons

119132
   
Total number of transcript structures 532549
Avg. contexts per unique exon 218789 / 119132 = 1.8

Avg. contexts per unique intron

275335 / 155949 = 1.8
   
Genes with >1 splice pattern 11406
Genes with delineated events
8010
   
Total number of exon events 21659
Exon Isoform events 5290
Cassette exon events 11996
Alternating exon events 898
Intron retention events 3475
   
Intron Isoform events 9619
Total number of intron events 25988
Events per gene 3.2

Distribution statistics

Various distributions are located on the distribution statistics page (genes per classes, intron types, event types, length of retained introns and cassette exons, effective length change of exon isoforms).

 

Data files

Copyright Notice
This ASD database has been generated within a research programme financed by the European Community1. ExonHit Therapeutics SA has been granted commercial exploitation rights to this database under the EU funded consortium, of which it is a member, and the database is protected by EC Directive2.

ExonHit currently holds an option to an exclusive license to the contents of the Alternative Splicing Database for commercial use including without limitation, providing services, and designing products (Commercial Rights). Consequently, such Commercial Rights are not currently available to anyone else. For up to date contact information for ExonHit Therapeutics SA, please see its website: www.exonhit.com.

The database is covered by paragraphs 2-17 of the EBI's normal terms of use, to be found at www.ebi.ac.uk/Information/termsofuse

By clicking the button below, or hyperlinking to pages beyond this notice, you indicate your agreement with these terms.

1. DIRECTIVE 96/9/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 11 March 1996 on the legal protection of databases.

2. DIRECTIVE 96/9/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 11 March 1996 on the legal protection of databases.
spacer
spacer